Using TCGA cohort data as a training set, we constructed a prognostic risk scoring model based on 9 metabolic genes associated with TP53 to quantitatively score the risk of an individual BC patient, so as to improve individualized cancer treatment and monitoring. Here, TP53 is linked to breast cancer.